WEBULL
WebtradeDownload

UBE (TSE:4208) Stock Climbs On Revenue Growth Despite EPS Pressure

Simply Wall St · 2d ago

UBE stock came into this earnings print on a strong run, with the share price at ¥3,350 after a powerful 90 day climb. The headline from Q1 2027 is not the top line. Total revenue sat at ¥121,896m, yet basic earnings per share reached ¥43.15 and net income landed at ¥4,192m. For a chemicals producer that only recently returned to profitability and still carries balance sheet pressure, this early quarter profit performance is what really matters for anyone thinking beyond today’s price reaction.

Love UBE’s return to profitability but still wary of the balance sheet pressure and cyclicality of chemicals earnings? Take a look at the list of solid balance sheet and fundamentals stocks (40 results).

Q1 2027 Earnings Summary

  • Revenue, Q1 2027 vs. Q1 2026: ¥121,896m vs. ¥100,459m (revenue higher year on year)
  • Net Income, Q1 2027 vs. Q1 2026: ¥4,192m vs. ¥4,361m (net income slightly lower year on year)
  • Basic EPS, Q1 2027 vs. Q1 2026: ¥43.15 vs. ¥44.90 (earnings per share slightly lower year on year)
  • Trailing 12 Month Net Income, Q1 2027 vs. Q1 2026: ¥23,703m vs. a loss of ¥5,259m (moved from loss to profit over the last 12 months)

Prefer clear visuals instead of another wall of earnings tables and balance sheet figures? See UBE’s full financial picture, with a focus on its balance sheet strength, in the company report for UBE.

TSE:4208 Trailing 12-Month Earnings & Revenue History as at Aug 2026
TSE:4208 Trailing 12-Month Earnings & Revenue History as at Aug 2026

Revenue Momentum Supports UBE’s Diversified Growth Story

For investors leaning positive on UBE, the latest quarter gives some backing. Revenue reached ¥121,896m compared with ¥100,459m a year earlier, which points to healthier top line momentum across the portfolio. At the same time, UBE stayed in the black with Q1 2027 net income of ¥4,192m and basic EPS of ¥43.15. The shift from a trailing 12 month loss of ¥5,259m to a profit of ¥23,703m fits a narrative of a diversified industrial platform that is holding its earnings footing.

Profitability Edges Tight Keep Bears Focused On Cyclicality

The cautious view on UBE still has some support. Net income in Q1 2027 of ¥4,192m is slightly lower than the prior ¥4,361m, and basic EPS slipped from ¥44.90 to ¥43.15 despite higher revenue. That hints at margin pressure, which matters for a chemicals and industrial group exposed to global cycles. The prior trailing 12 month loss also shows that profitability recovery is recent. For anyone worried about cyclicality and balance sheet pressure, these numbers suggest the story has improved but is not yet free of earnings fragility.

After a recent loss and with debt and dividends putting pressure on cash generation, it is worth asking whether these margin strains are just early signs. Review our risk analysis for UBE which shows 3 important warning signs for a concise breakdown of UBE’s risk score, hidden structural flags and how they could affect future earnings resilience.

Keep Your Edge With UBE And Beyond

If UBE’s shift back into profitability has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and wait for an entry point that fits your plan. After you own UBE or any other stock, use the Portfolio Command Center to cut through noise and focus on the key developments that matter for your holdings. For longer term thinking, tap into the Community to see how other investors are weighing the same earnings trends and balance sheet questions. By spotting both hidden catalysts and emerging risks early, you give yourself a better chance of staying a step ahead of the market.

Seeking Alternatives Beyond UBE Today

Fresh stock stories can move from quiet to breakout fast, while data is still under the radar for now. Scan them before momentum is fully caught and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.